France Women’s Health Market Size & Outlook, 2023-2030
France women’s health market, 2018-2030 (US$M)
Related Markets
France women’s health market highlights
- The France women’s health market generated a revenue of USD 1,770.3 million in 2023 and is expected to reach USD 2,722.7 million by 2030.
- The France market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2023.
- Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.
Women’s health market data book summary
| Market revenue in 2023 | USD 1,770.3 million |
| Market revenue in 2030 | USD 2,722.7 million |
| Growth rate | 6.3% (CAGR from 2023 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Endometriosis & Uterine Fibroids |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, France accounted for 4.0% of the global women’s health market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany women’s health market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 3,031.4 million by 2030.
Contraceptives was the largest segment with a revenue share of 35.55% in 2023. Horizon Databook has segmented the France women’s health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
France's women’s health market is expected to grow at a lucrative rate over the forecast period. The healthcare system in France is well-established, owing to its quality, accessibility, and affordability for all its citizens. Moreover, rapidly aging population & obesity among women and growing awareness campaigns in the country are supporting the market expansion.
According to the World Bank, in 2022, the population of women aged 65 and above was around 8.35 million in France. Moreover, according to a study published by WHO, the prevalence of obesity in French women is expected to increase from ~20% in 2020 to ~29% by 2030.
Implementation of national programs & initiatives to reduce the prevalence of obesity and increase in the number of expansion plans & partnerships by manufacturers are among the key factors expected to drive the women’s health market in France during the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women’s Health Market Scope
Women’s Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France women’s health market size, by application, 2018-2030 (US$M)
France Women’s Health Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
